Comparison of Scores for Early Brain Damage Assessment at Intensive Care Unit Admission After Cardiac Arrest

Last updated: January 29, 2024
Sponsor: AfterROSC
Overall Status: Active - Recruiting

Phase

N/A

Condition

Neurologic Disorders

Heart Attack (Myocardial Infarction)

Heart Failure

Treatment

Calculation of early prognosis score

Clinical Study ID

NCT05606809
2022-A01811-42
  • Ages > 18
  • All Genders

Study Summary

Even in patients with successful return of spontaneous circulation (ROSC), outcome after cardiac arrest remains poor. The overall in-hospital survival rate widely varies both worldwide and across communities, from 1 to 4 folds according to circumstances of arrest and post-resuscitation interventions. Several studies have already shown that early interventions performed after ROSC, such as treatment of the cause, targeted temperature management, optimal hemodynamic management and extra-corporeal life support in selected patients, could improve the outcome in post-cardiac arrest patients. However, the decision process regarding the allocation of these resources, in parallel with the management of patients' proxies, remains a complex challenge for physicians facing these situations. Consequently, several prediction models and scores have been developed in order to stratify the risk of unfavorable outcome and to discriminate the best candidates for post-resuscitation interventions. Overall, several scores exist, but external validation are lacking and direct comparisons are needed to assess relative interest of scoring systems. Indeed, establishing the optimal scoring system is crucial, for optimal treatment allocation and appropriate information to relatives.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • all adult patients, major, admitted to intensive care after cardiac arrest (after bothin and out-of hospital cardiac arrest),
  • comatose (defined by Glasgow score ≤ 8) on admission,

Exclusion

Exclusion Criteria:

  • cardiac arrest occurring intra-hospital,
  • minor patient,
  • major patient under guardianship,
  • protected persons,
  • prior inclusion in the study

Study Design

Total Participants: 4500
Treatment Group(s): 1
Primary Treatment: Calculation of early prognosis score
Phase:
Study Start date:
November 02, 2022
Estimated Completion Date:
December 02, 2025

Connect with a study center

  • CHU Nantes

    Nantes, Pays De Loire
    France

    Active - Recruiting

  • Hopital Jacques Cartier

    Massy,
    France

    Active - Recruiting

  • Clinique Ambroise Paré

    Neuilly-sur-Seine,
    France

    Active - Recruiting

  • APHP, Cochin

    Paris,
    France

    Active - Recruiting

  • CH Versailles

    Versailles,
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.